| Financial Year |
March 31 2023 |
| Monetary Funds |
191,017,589.06 |
| Held-for-trading Financial Assets |
115,000,000.00 |
| Notes Receivable |
31,036,588.49 |
| Accounts Receivable |
231,545,154.90 |
| Advances to Suppliers |
3,090,458.08 |
| Other Receivables |
2,367,555.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
187,083,858.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,498,332.42 |
| Total Current Assets |
827,286,172.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,716,448.03 |
| Investment Properties |
4,255,190.47 |
| Fixed Assetes |
360,894,650.31 |
| Under-construction Projects |
99,530,444.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
74,504,617.10 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,507,282.17 |
| Deferred Income Tax Assets |
4,873,430.53 |
| Other Non-Current Assets |
6,266,082.81 |
| Sub-Total of Non-Current Assets |
590,625,331.75 |
| Total Assets |
1,417,911,503.99 |
| Short-Term Loans |
48,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
44,680,780.12 |
| Accounts Payable |
98,016,330.46 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,364,047.38 |
| Taxes Payable |
6,052,193.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
985,211.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
80,067.51 |
| Other Current Liabilities |
11,233,103.80 |
| Sub-Total of Current Liabilities |
226,625,593.02 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,394,966.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
30,810,997.27 |
| Total Liabilities |
257,436,590.29 |
| Paid-In Capital(Or Share Stock) |
88,000,000.00 |
| Capital Surplus |
572,467,044.75 |
| Surplus Reserve |
44,000,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
453,955,705.95 |
| Minority Stockholder's Interest |
2,052,163.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,158,422,750.70 |
| Owner's Equity（Stockholder's Equity） |
1,160,474,913.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,417,911,503.99 |
